Associations of Lp(a) with CV morbidity and mortality
Lp(a) meeting Pia Kamstrup shares data of two general population studies that reveal the effects of elevated Lp(a) levels on CV events, and effects of Lp(a) risk genotypes, which are consistent with Lp(a) being a causal risk factor for CVD.
This lecture by Pia Kamstrup was part of the EAS-endorsed satellite meeting "The imminent danger of Lp(a): Time to face the challenge" held prior to the 87th EAS congress in Maastricht
Pia Kamstrup, Head of Department at the Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Denmark
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme.
Share this page with your colleagues and friends: